CAS 1190848-23-7

Formule : C24H27FO2

InChI : InChI=1S/C24H27FO2/c1-14-11-19-20(24(5,6)10-9-23(19,3)4)13-18(14)15(2)16-7-8-17(22(26)27)21(25)12-16/h7-8,11-13H,2,9-10H2,1,3-6H3,(H,26,27)

Code InChI : LWKAWHRSPCHMPJ-UHFFFAOYSA-N

SMILES : CC1=CC2=C(C=C1C(=C)C3=CC(=C(C=C3)C(=O)O)F)C(CCC2(C)C)(C)C

Fluorobexarotene

CAS : 1190848-23-7

Fluorobexarotene

Formule : C₂₄H₂₇FO₂

Degré de pureté : 99%

Masse moléculaire : 366.47

Ref: 54-BUP09394

2-Fluoro-4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid

CAS : 1190848-23-7

Ref: IN-DA0096WS

Fluorobexarotene

Produit contrôlé

CAS : 1190848-23-7

Formule : C₂₄H₂₇FO₂

Couleur et forme : Neat

Masse moléculaire : 366.468

Ref: TR-F597938

Fluorobexarotene

CAS : 1190848-23-7

Fluorobexarotene, a potent RXR agonist, has 75% higher affinity than Bexarotene with Ki of 12 nM and EC50 of 43 nM for RXRα.

Formule : C₂₄H₂₇FO₂

Degré de pureté : 99.08%

Couleur et forme : Solid

Masse moléculaire : 366.4684

Ref: TM-T11303

Fluorobexarotene

CAS : 1190848-23-7

Fluorobexarotene is a fatty acid that has been shown to induce the expression of inflammatory genes in animal models. It has also been shown to inhibit the growth of human cancer cells in vitro and in vivo. Fluorobexarotene is used for the diagnosis of x-linked adrenoleukodystrophy and is currently being studied as a treatment for liver cancer. This molecule is also an agonist of retinoic acid receptors, which may be responsible for its effects on gene transcription.

Formule : C₂₄H₂₇FO₂

Degré de pureté : Min. 95%

Masse moléculaire : 366.5 g/mol

Ref: 3D-QXB84823